secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANI PHARMACEUTICALS INC (ANIP)
CIK:        0001023024
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001104659-25-045937
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

ANI Pharmaceuticals supplements proxy statement on stock plan share reserve
---------------------------------------------------------------------------

- As of March 24, 2025, total stock options outstanding: 571,880 (weighted avg exercise price $46.28, remaining term 3.68 yrs).
- Performance/restricted stock awards: 1,866,153 shares; shares available for future grant: 1,177,800.
- Inducement grants (non-shareholder approved) comprise 184,989 options at avg exercise price $29.63, term 5.57 yrs.
- Company seeks approval of Amended and Restated 2022 Stock Incentive Plan; no changes to other proposals or meeting date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1023024/000110465925045937/0001104659-25-045937-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1023024/000110465925045937/tm2514446d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-045937

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer